Latest Ratios: P/E Ratio -0.8x · EV/EBITDA N/A · ROE -46.6%. (2005–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $125M | $84M | $25M | $12M | $74M | $73M | $48M | $27M | $34M | $768968 | $1M |
| Enterprise Value | $116M | $76M | $27M | $7M | $64M | $71M | $48M | $29M | $35M | $2M | $3M |
| P/E Ratio → | -0.82 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | — | — | — | — | 16.94 | — | 393.15 | 14.70 | 7.84 | 0.16 | 0.18 |
| P/B Ratio | 0.21 | 0.87 | — | 3.31 | 7.49 | 58.88 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | 14.64 | — | 393.38 | 15.98 | 8.18 | 0.49 | 0.49 |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | 92.6% | — | -156.5% | 18.9% | 17.7% | 17.8% | 15.3% |
| Operating Margin | — | — | — | — | -288.4% | — | -5597.8% | -277.7% | -52.5% | -46.4% | -44.7% |
| Net Profit Margin | — | — | — | — | -460.3% | — | -11122.5% | -421.7% | -75.7% | -80.0% | -29.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -46.6% | -46.6% | -2088.7% | -224.7% | -361.5% | -2041.6% | — | — | — | — | — |
| ROA | -34.4% | -34.4% | -278.0% | -138.8% | -150.6% | -288.6% | -370.5% | -321.0% | -198.0% | -204.3% | -68.6% |
| ROIC | -30.6% | -30.6% | — | — | — | — | — | — | — | — | — |
| ROCE | -30.1% | -30.1% | -1356.2% | -204.8% | -221.2% | -735.5% | — | — | — | — | — |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.00 | 0.00 | — | 0.78 | 0.26 | 7.98 | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | -0.09 | — | -1.36 | -1.02 | -1.89 | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -6.87 | -6.87 | -10.06 | -35.99 | -1.57 | -0.70 | -1.12 | -1.70 | -1.89 | -5.99 | -8.31 |
Net cash position: cash ($9M) exceeds total debt ($342791)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.61 | 2.61 | 0.60 | 1.77 | 3.31 | 1.07 | 0.65 | 0.34 | 0.31 | 0.20 | 0.24 |
| Quick Ratio | 2.61 | 2.61 | 0.60 | 1.77 | 3.31 | 1.07 | 0.65 | 0.34 | 0.27 | 0.16 | 0.19 |
| Cash Ratio | 2.36 | 2.36 | 0.60 | 1.77 | 3.31 | 1.07 | 0.65 | 0.33 | 0.20 | 0.02 | 0.03 |
| Asset Turnover | — | — | — | — | 0.32 | — | 0.03 | 0.68 | 2.05 | 4.10 | 2.29 |
| Inventory Turnover | — | — | — | — | — | — | — | 206.17 | 17.40 | 17.73 | 17.28 |
| Days Sales Outstanding | — | — | — | — | — | — | — | 12.75 | 27.19 | 51.92 | 49.02 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.4% | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 47.8% |
| Total Shareholder Yield | 0.4% | 0.6% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 47.8% |
| Shares Outstanding | — | $63M | $2M | $1M | $1M | $734264 | $544776 | $451346 | $215772 | $96121 | $35719 |
Regulatory and Dilution Risk
According to recent market data, USBC's valuation is characterized by a lack of traditional revenue-based multiples, with a P/B ratio of 0.20, suggesting that the market is pricing the firm based on the binary probability of a future technological breakthrough rather than current fundamental performance metrics.
The absence of P/E and P/S multiples reflects the company's pre-revenue status, rendering standard valuation models ineffective for assessing intrinsic value. Investors should monitor whether the current discount to book value represents a genuine opportunity or a reflection of the market's skepticism regarding the company's ability to commercialize its Bio-RFID technology.
As reported in financial statements, USBC's ROIC has remained consistently negative, reaching -14.8% in 2026Q2, which highlights the company's inability to generate returns on the capital deployed into its long-term R&D and hardware development initiatives since its inception as a public entity.
The negative ROIC trend underscores the structural challenge of funding high-cost R&D without a corresponding revenue stream to offset operational expenses. This persistent decay in capital efficiency suggests that the company is currently destroying shareholder value, necessitating a shift toward a more sustainable licensing or commercial model to reverse this trajectory.
Based on quarterly data, USBC's current ratio plummeted to 0.32 in 2026Q2 from 2.61 in 2025Q4, signaling a severe tightening of liquidity that leaves the firm with limited buffers to cover its immediate operational obligations and ongoing clinical trial expenses in the coming quarters.
The rapid decline in the current ratio indicates that the company's ability to meet short-term liabilities is increasingly dependent on external financing rather than internal cash generation. This liquidity profile warrants close monitoring, as any delay in securing additional capital could jeopardize the company's ability to maintain its regulatory and research timelines.
As disclosed in recent filings, the current ratio is a frequently misapplied metric for USBC, as it fails to account for the company's reliance on dilutive equity financing to bridge its operational funding gaps, thereby obscuring the true nature of its ongoing solvency and liquidity risks.
While a current ratio of 0.32 suggests immediate distress, it does not fully capture the company's ability to access capital markets through at-the-market offerings. Analysts should instead focus on the 'cash burn rate' relative to available liquidity to better understand the firm's actual runway before the next dilutive event becomes necessary.
Includes 30+ ratios · 18 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying USBC stock.
USBC, Inc.'s current P/E ratio is -0.8x. This places it at the 50th percentile of its historical range.
USBC, Inc.'s return on equity (ROE) is -46.6%. The historical average is -212.2%.
Based on historical data, USBC, Inc. is trading at a P/E of -0.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.